Low-dose radiation for Parkinson's neuroinflammation: what do doctors think?

Mayo Clinic has started the first trial of low-dose radiation therapy as an anti-inflammatory approach in patients with early-stage Parkinson's disease. The aim is to see whether irradiating the brain regions affected by the disease can slow its progression. This is an early test of an idea: efficacy and safety have not been established. What we'll discuss: — How convincing is neuroinflammation as a therapeutic target in Parkinson's disease, and is it a driver or a consequence of dopaminergic neuron loss? — What concerns would you have about brain irradiation in early-stage patients even at a low dose, and which endpoints would you find convincing? — Do you see a place for such an approach alongside current symptomatic treatment, or is it too early to say? For USMLE: neuroinflammation and loss of dopaminergic neurons in the substantia nigra are a core part of Parkinson's pathogenesis, and news like this is a handy way to review the mechanisms. Full article: drasiiavinograd.com/blog/parkinson-s-disease-low-dose-radiation-trial- Source: Medical Xpress medicalxpress.com/news/2026-10-kind-trial-dose-brain-inflammation.html